Información de Charles River Laboratories International Inc, dividendo de Charles River Laboratories International Inc, actividades de los accionistas y más

Más Datos de Charles River Laboratories International Inc Compañía

Charles River Laboratories International, Inc. is a drug development company. It provides essential products and services to help pharmaceutical and biotechnology companies, government agencies and academic institutions around the globe accelerate their research and drug development efforts. Its Research Models and Services segment includes three businesses that provide foundational tools that enable its clients to discover new molecules: Research Models, Research Model Services, and Cell Solutions. Its Discovery and Safety Assessment segment provides regulated and non-regulated DSA services to support the research, development, and regulatory-required safety testing of potential new drugs, including therapeutic discovery and optimization plus in vitro and in vivo studies, laboratory support services, and strategic non-clinical consulting and program management to support product development. Its Manufacturing Solutions segment includes Microbial Solutions and Biologics Solutions.

Información de Charles River Laboratories International Inc



Símbolo de cotizaciónCRL

Nombre de la empresaCharles River Laboratories International Inc

Fecha de salida a bolsaJun 23, 2000

Director ejecutivoFoster (James C)

Número de empleados18600

Tipo de seguridadOrdinary Share

Fin del año fiscalJun 23

Dirección251 Ballardvale St

CiudadWILMINGTON

Bolsa de valoresNASDAQ OMX NASDAQ Basic NYSE

PaísUnited States of America

Código postal01887

Teléfono17812226000

Sitio Webhttps://www.criver.com/

Símbolo de cotizaciónCRL

Fecha de salida a bolsaJun 23, 2000

Director ejecutivoFoster (James C)

Ejecutivos de Charles River Laboratories International Inc



Nombre

Nombre/Posición

Posición

Accionistas

Cambio

Mr. James C. Foster

Chairman of the Board, President, Chief Executive Officer

276.94K

+0.67%

Ms. Birgit Girshick

Chief Operating Officer, Corporate Executive Vice President

54.42K

-17.91%

Ms. Victoria L. (Vicky) Creamer

Corporate Executive Vice President, Chief People Officer

16.96K

-27.32%

Ms. Shannon M. Parisotto

Corporate Executive Vice President - Discovery and Safety Assessment Management

16.05K

+19.74%

Mr. Joseph W. LaPlume

Corporate Executive Vice President - Corporate Development and Strategy

10.87K

-45.20%

Ms. Virginia M. (Gina) Wilson, CPA

Independent Director

6.35K

+22.65%

Dr. Nancy C. Andrews, M.D., Ph.D.

Independent Director

5.40K

+26.62%

Ms. Reshema Kemps-Polanco

Independent Director

4.56K

+43.24%

Dr. Craig B. Thompson, M.D.

Independent Director

3.85K

+37.34%

Mr. Abraham N. (Abe) Ceesay

Independent Director

2.38K

+60.32%

Nombre

Nombre/Posición

Posición

Accionistas

Cambio

Mr. James C. Foster

Chairman of the Board, President, Chief Executive Officer

276.94K

+0.67%

Ms. Birgit Girshick

Chief Operating Officer, Corporate Executive Vice President

54.42K

-17.91%

Ms. Victoria L. (Vicky) Creamer

Corporate Executive Vice President, Chief People Officer

16.96K

-27.32%

Ms. Shannon M. Parisotto

Corporate Executive Vice President - Discovery and Safety Assessment Management

16.05K

+19.74%

Mr. Joseph W. LaPlume

Corporate Executive Vice President - Corporate Development and Strategy

10.87K

-45.20%

Ms. Virginia M. (Gina) Wilson, CPA

Independent Director

6.35K

+22.65%

Desglose de ingresos

Divisa: USDActualizado: lun., 6 de abr

FY2025

FY2025Q4

FY2025Q3

FY2025Q2

FY2025Q1

FY2024

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021

FY2020

FY2019

FY2018

FY2017

FY2016

FY2015

Por negocioUSD

Nombre

Ganancia

Proporción

DSA

2.40B

59.84%

RMS

846.08M

21.07%

Manufacturing

766.41M

19.09%

Por regiónUSD

Nombre

Ganancia

Proporción

United States

2.14B

53.34%

Europe

1.10B

27.46%

Canada

501.02M

12.48%

Asia Pacific (Region)

205.02M

5.11%

Other

64.86M

1.62%

Por negocio

Por región

Por negocioUSD

Nombre

Ganancia

Proporción

DSA

2.40B

59.84%

RMS

846.08M

21.07%

Manufacturing

766.41M

19.09%

Estadísticas de accionistas

Actualizado: jue., 14 de may

Accionistas

Tipos de accionistas

Accionistas

Proporción

Vanguard Capital Management, LLC

6.65%

BlackRock Institutional Trust Company, N.A.

5.97%

Vanguard Portfolio Management, LLC

4.76%

Allspring Global Investments, LLC

4.14%

State Street Investment Management (US)

3.89%

Otro

74.59%

Accionistas

Proporción

Vanguard Capital Management, LLC

6.65%

BlackRock Institutional Trust Company, N.A.

5.97%

Vanguard Portfolio Management, LLC

4.76%

Allspring Global Investments, LLC

4.14%

State Street Investment Management (US)

3.89%

Otro

74.59%

Tipos de accionistas

Accionistas

Proporción

Investment Advisor

50.79%

Investment Advisor/Hedge Fund

50.41%

Hedge Fund

9.44%

Research Firm

2.78%

Pension Fund

1.52%

Sovereign Wealth Fund

1.01%

Individual Investor

0.95%

Bank and Trust

0.75%

Family Office

0.09%

Participación institucional



Actualizado: dom., 5 de abr

Periodo del informe

Número de instituciones

Acciones mantenidas

Proporción

Cambio

2026Q1

1429

56.13M

116.51%

-7.96M

2025Q4

1367

52.25M

129.09%

+28.56K

2025Q3

1413

52.22M

129.54%

+64.86K

2025Q2

1411

52.12M

127.74%

-2.86M

2025Q1

1414

54.69M

123.53%

-5.98M

2024Q4

1410

54.25M

114.75%

+1.17M

2024Q3

1372

53.38M

114.53%

-33.66K

2024Q2

1378

53.46M

111.45%

+347.48K

2024Q1

1371

53.18M

111.09%

-4.05M

2023Q4

1405

52.96M

112.24%

-202.82K

Actividad de los accionistas



Nombre

Acciones mantenidas

Proporción

Cambio

Cambio %

Fecha

BlackRock Institutional Trust Company, N.A.

2.88M

5.85%

+56.48K

+2.00%

Dec 31, 2025

Allspring Global Investments, LLC

2.00M

4.05%

-182.34K

-8.37%

Dec 31, 2025

State Street Investment Management (US)

1.87M

3.8%

+40.53K

+2.21%

Dec 31, 2025

Invesco Advisers, Inc.

1.78M

3.61%

+1.63M

+1113.97%

Dec 31, 2025

Wellington Management Company, LLP

1.75M

3.55%

-1.44M

-45.17%

Dec 31, 2025

Harris Associates L.P.

1.68M

3.41%

+204.52K

+13.88%

Dec 31, 2025

Dimensional Fund Advisors, L.P.

1.44M

2.93%

+311.32K

+27.53%

Dec 31, 2025

Fidelity Management & Research Company LLC

1.55M

3.15%

+1.15M

+293.11%

Dec 31, 2025

ETFs relacionados



Actualizado: sáb., 6 de dic

Nombre

Proporción

Invesco S&P 500 Equal Weight Health Care ETF

1.92%

Schwab Ariel Opportunities ETF

1.82%

iShares Health Innovation Active ETF

1.74%

First Trust NASDAQ Pharmaceuticals ETF

1.71%

ROBO Global Healthcare Technology & Innovation ETF

1.69%

VanEck Biotech ETF

1.44%

Franklin Genomic Advancements ETF

1.42%

WisdomTree US Value Fund

1.15%

Invesco S&P 500 High Beta ETF

1.14%

Pacer Lunt Large Cap Alternator ETF

0.97%

Invesco S&P 500 Equal Weight Health Care ETF

Proporción1.92%

Schwab Ariel Opportunities ETF

Proporción1.82%

iShares Health Innovation Active ETF

Proporción1.74%

First Trust NASDAQ Pharmaceuticals ETF

Proporción1.71%

ROBO Global Healthcare Technology & Innovation ETF

Proporción1.69%

VanEck Biotech ETF

Proporción1.44%

Franklin Genomic Advancements ETF

Proporción1.42%

WisdomTree US Value Fund

Proporción1.15%

Invesco S&P 500 High Beta ETF

Proporción1.14%

Pacer Lunt Large Cap Alternator ETF

Proporción0.97%

Dividendos



Un total de 0.00 USD se ha distribuido en dividendos durante los últimos 5 años.

Fecha

Dividendos

Fecha de registro

Fecha de pago

Fecha ex-dividendo

Sin datos

División de acciones



Fecha

Fecha ex-dividendo

Tipo

Relación

Sin datos

Fecha

Fecha ex-dividendo

Tipo

Relación

Sin datos